We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$55.2M
(+29%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
43.97%
Holding
439
New
112
Increased
115
Reduced
72
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$24.2M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$2.84M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$2.46M |
| 4 |
ExxonMobil
XOM
|
+$2.14M |
| 5 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$2.22M |
| 2 |
Microsoft
MSFT
|
+$2.06M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.93M |
| 4 |
Blackrock
BLK
|
+$1.33M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.37% |
| 2 | Consumer Discretionary | 6.6% |
| 3 | Industrials | 5.97% |
| 4 | Consumer Staples | 5.81% |
| 5 | Healthcare | 5.59% |
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q2 2020 Portfolio in Review
As of Q2 2020, Leelyn Smith held 439 positions worth $243M, up 29% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Leelyn Smith deployed $46.5M of net new capital in Q2 2020, opening 112 new positions and adding to 115 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8.3% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $2.22M trimmed.
- Leelyn Smith's largest Q2 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
- Leelyn Smith added most to 3M in Q2 2020, an estimated $24.2M increase.
- Leelyn Smith's biggest Q2 2020 reduction was Clorox, cutting an estimated $2.22M.
- Leelyn Smith fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $333K.
- Leelyn Smith's ten largest holdings make up 44% of its $243M portfolio in Q2 2020.
- Leelyn Smith opened 112 new positions and closed 39 in Q2 2020.
- Leelyn Smith's portfolio value rose 29% quarter-over-quarter to $243M.
Based on Leelyn Smith's 13F filing for Q2 2020, filed 6 Aug 2020.